Z

Zhejiang Wolwo Bio-Pharmaceutical Co Ltd
SZSE:300357

Watchlist Manager
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd
SZSE:300357
Watchlist
Price: 22.18 CNY -4.81% Market Closed
Market Cap: 11.6B CNY
Have any thoughts about
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd?
Write Note

Wall Street
Price Targets

Price Targets Summary
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd

Wall Street analysts forecast Zhejiang Wolwo Bio-Pharmaceutical Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Zhejiang Wolwo Bio-Pharmaceutical Co Ltd is 27.45 CNY with a low forecast of 27.18 CNY and a high forecast of 28.26 CNY.

Lowest
Price Target
27.18 CNY
23% Upside
Average
Price Target
27.45 CNY
24% Upside
Highest
Price Target
28.26 CNY
27% Upside
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd Competitors:
Price Targets
CORT
Corcept Therapeutics Inc
33% Upside
CLSD
Clearside Biomedical Inc
467% Upside
2005
SSY Group Ltd
68% Upside
170900
Dong-A ST Co Ltd
46% Upside
TORNTPHARM
Torrent Pharmaceuticals Ltd
12% Upside
REC
Recordati Industria Chimica e Farmaceutica SpA
7% Upside
2096
Simcere Pharmaceutical Group Ltd
36% Upside
OCUL
Ocular Therapeutix Inc
110% Upside

Revenue
Forecast

Revenue Estimate
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd

For the last 8 years the compound annual growth rate for Zhejiang Wolwo Bio-Pharmaceutical Co Ltd's revenue is 16%. The projected CAGR for the next 3 years is 18%.

16%
Past Growth
18%
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd

For the last 8 years the compound annual growth rate for Zhejiang Wolwo Bio-Pharmaceutical Co Ltd's operating income is 12%. The projected CAGR for the next 3 years is 26%.

12%
Past Growth
26%
Estimated Growth
Estimates Accuracy
-11%
Average Miss

Net Income
Forecast

Net Income Estimate
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd

For the last 8 years the compound annual growth rate for Zhejiang Wolwo Bio-Pharmaceutical Co Ltd's net income is 13%. The projected CAGR for the next 3 years is 17%.

13%
Past Growth
17%
Estimated Growth
Estimates Accuracy
-6%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Zhejiang Wolwo Bio-Pharmaceutical Co Ltd's stock price target?
Price Target
27.45 CNY

According to Wall Street analysts, the average 1-year price target for Zhejiang Wolwo Bio-Pharmaceutical Co Ltd is 27.45 CNY with a low forecast of 27.18 CNY and a high forecast of 28.26 CNY.

What is Zhejiang Wolwo Bio-Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
18%

For the last 8 years the compound annual growth rate for Zhejiang Wolwo Bio-Pharmaceutical Co Ltd's revenue is 16%. The projected CAGR for the next 3 years is 18%.

What is Zhejiang Wolwo Bio-Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
26%

For the last 8 years the compound annual growth rate for Zhejiang Wolwo Bio-Pharmaceutical Co Ltd's operating income is 12%. The projected CAGR for the next 3 years is 26%.

What is Zhejiang Wolwo Bio-Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
17%

For the last 8 years the compound annual growth rate for Zhejiang Wolwo Bio-Pharmaceutical Co Ltd's net income is 13%. The projected CAGR for the next 3 years is 17%.

Back to Top